Статья

Management of acute ischemic stroke in patients with COVID-19 infection: Report of an international panel

Adnan I. QureshiZeenat Qureshi Stroke Institute and Department of Neurology, University of Missouri, Columbia, MO, USAFoad Abd-AllahDepartment of Neurology, Kasralainy school of Medicine, Cairo University, Cairo, EgyptFahmi Al-SenaniNeurology Department, National Neuroscience Institute, King Fahad Medical City, Riyadh, Saudi ArabiaEmrah AytaçDepartment of Neurology, University of FIRAT, Elazig TurkeyAfshin Borhani‐HaghighiClinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, IranAlfonso CicconeDepartment of Neurosciences, Hospital Carlo Poma, ASST di Mantova, Mantua, ItalyCamilo R. GomezDepartment of Neurology, University of Missouri, MO, USAErdem GürkaşStroke Center, Department of Neurology, Kartal Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, TurkeyChung Y. HsuGraduate Institute of Clinical Medical Science, China Medical University, Taichung, TaiwanVishal JaniDepartment of Neurology, Creighton University Medical Center/CHI Health, Omaha, NE, USALiqun JiaoDepartment of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, ChinaAdam KobayashiDepartment of Neurology and Interventional Stroke Treatment Centre, Kazimierz Pulaski University of Technology and Humanities, Radom, PolandJun LeeDepartment of Neurology, Yeungnam University School of Medicine, Daegu, KoreaJahanzeb LiaqatPakistan Emirates Military Hospital (J.L.), Rawalpindi, PakistanMikaël MazighiDepartment of Interventional Neuroradiology, Rothschild Foundation Hospital, University of Paris, Laboratory of Vascular Translational Sciences, Paris, FranceRajsrinivas ParthasarathyStroke & Neurointervention Artemis Hospitals, Gurugram, IndiaThorsten SteinerDepartment of Neurology, Klinikum Frankfurt Höchst, Frankfurt and Heidelberg University Hospital, Heidelberg, GermanyM. Fareed K. SuriSt Cloud Hospital, St Cloud, MN, USAḰazunori ToyodaDepartment of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, JapanMarc RibóDepartment of Neurology, Hospital Vall d'Hebron, Universitat Autonoma de Barcelona, SpainFernando Góngora‐RiveraServicio de Neurología, Hospital Universitario José Eleuterio González de la Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México; Instituto de Neurología y Neurocirugía, Hospital Zambrano Hellion, Tecnológico de Monterrey, San Pedro, Nuevo León, MéxicoJamary Oliveira‐FilhoDepartment of Biomorphology, Federal University of Bahia, Salvador, BrazilGuven UzunBeverly Hills Pain Institute and Neurology, Beverly Hills, CA, USAYongjun WangTiantan Comprehensive Stroke Center, Beijing Tiantan Hospital, Capital Medical University Beijing, China

2020en

ABI

Аннотация

BACKGROUND AND PURPOSE: On 11 March 2020, World Health Organization (WHO) declared the COVID-19 infection a pandemic. The risk of ischemic stroke may be higher in patients with COVID-19 infection similar to those with other respiratory tract infections. We present a comprehensive set of practice implications in a single document for clinicians caring for adult patients with acute ischemic stroke with confirmed or suspected COVID-19 infection. METHODS: The practice implications were prepared after review of data to reach the consensus among stroke experts from 18 countries. The writers used systematic literature reviews, reference to previously published stroke guidelines, personal files, and expert opinion to summarize existing evidence, indicate gaps in current knowledge, and when appropriate, formulate practice implications. All members of the writing group had opportunities to comment in writing on the practice implications and approved the final version of this document. RESULTS: This document with consensus is divided into 18 sections. A total of 41 conclusions and practice implications have been developed. The document includes practice implications for evaluation of stroke patients with caution for stroke team members to avoid COVID-19 exposure, during clinical evaluation and performance of imaging and laboratory procedures with special considerations of intravenous thrombolysis and mechanical thrombectomy in stroke patients with suspected or confirmed COVID-19 infection. CONCLUSIONS: These practice implications with consensus based on the currently available evidence aim to guide clinicians caring for adult patients with acute ischemic stroke who are suspected of, or confirmed, with COVID-19 infection. Under certain circumstances, however, only limited evidence is available to support these practice implications, suggesting an urgent need for establishing procedures for the management of stroke patients with suspected or confirmed COVID-19 infection.

Перевод пока недоступен

Идентификаторы

DOI: 10.1177/1747493020923234

Цитирования и источники

Цитирований: 3Использованных источников: 0

Показатели — AkademScholar